De-worming medications :: Consumers survey results of for 3 quarter of 2013

Consumers survey results of for 3 quarter of 2013 in category

Antiparasitic / De-worming medications

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Ворміл (Mili Healthcare)	55.56%	5

2.		Вермокс (Janssen)	22.22%	2

2.	3	Левамізол (Elegant India)	22.22%	2

2.	3	Пірантел Польфарма (Polpharma S.A.)	22.22%	2

5.	3	Helmintox (Lab. Innotech International)	11.11%	1

5.	2	Декарис (Gedeon Richter)	11.11%	1

5.		Зентел (GlaxoSmithKline)	11.11%	1

5.	2	Пірантел (Genom Biotech)	11.11%	1

–.	~	~~Альбендазол (Ross Robbins)~~	~~11.11%~~	1

–.	~	~~Альбендазол-Здоров’я (Pharmaceutical company “Zdorovya”)~~	~~11.11%~~	1

–.		~~Більтрицид (Bayer)~~	~~0.00%~~	0

–.		~~Немозол (Ipca Laboratories Limited)~~	~~0.00%~~	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2013, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.